Literature DB >> 19833754

Risk factors for development of coronary artery disease in women with systemic lupus erythematosus.

Robert J Goldberg1, Murray B Urowitz, Dominique Ibañez, Mandana Nikpour, Dafna D Gladman.   

Abstract

OBJECTIVE: To ascertain coronary artery disease (CAD) outcomes and predictive factors in a prospective study of patients with systemic lupus erythematosus (SLE) and matched healthy controls.
METHODS: SLE patients and non-SLE age-matched controls without a history of CAD were recruited into a prospective study between 1997 and 1999. CAD events were assessed at clinic visit for SLE patients and through telephone interview and chart review for controls. All events were verified with patient medical records.
RESULTS: Followup information was available on 237 controls and 241 SLE patients. The mean followup time was 7.2 years. Univariate analyses identified age and postmenopausal status as predictors of CAD in both the groups. Sedentary lifestyle, hypertension, the presence of metabolic syndrome, and the number of Framingham risk factors were predictive in the control group only. The 10-year risk of CAD score was predictive in both groups but was not as marked in the SLE group as in the controls. None of the lipid subfractions were predictive for CAD in the SLE group, whereas in the controls, a high triglyceride level >or= 2.8 was predictive. Time-to-event multivariate analysis for CAD in all subjects revealed SLE itself, older age, and triglycerides >or= 2.8 to be highly predictive for CAD.
CONCLUSION: In a prospective study of patients with SLE and matched controls followed over a median of 8 years, patients with SLE developed significantly more CAD events than controls. Accounting for demographic variability, CAD risk factors, and lipid factors, SLE is an independent risk factor for the development of CAD.

Entities:  

Mesh:

Year:  2009        PMID: 19833754     DOI: 10.3899/jrheum.090011

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  15 in total

1.  Risk of Cerebrovascular Accidents and Ischemic Heart Disease in Cutaneous Lupus Erythematosus: A Population-Based Cohort Study.

Authors:  Abha G Singh; Cynthia S Crowson; Siddharth Singh; Mark Denis; P Davis; Hilal Maradit-Kremers; Eric L Matteson; Vaidehi R Chowdhary
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-11       Impact factor: 4.794

2.  Absence of β2 integrins impairs regulatory T cells and exacerbates CD4+ T cell-dependent autoimmune carditis.

Authors:  Stefanie Haasken; Jennifer L Auger; Bryce A Binstadt
Journal:  J Immunol       Date:  2011-07-27       Impact factor: 5.422

3.  The association of hypertriglyceridemia with cardiovascular events and pancreatitis: a systematic review and meta-analysis.

Authors:  M Hassan Murad; Ahmad Hazem; Fernando Coto-Yglesias; Svitlana Dzyubak; Shabnum Gupta; Irina Bancos; Melanie A Lane; Patricia J Erwin; Lars Berglund; Tarig Elraiyah; Victor M Montori
Journal:  BMC Endocr Disord       Date:  2012-03-31       Impact factor: 2.763

4.  Novel cardiovascular risk prediction models in patients with systemic lupus erythematosus.

Authors:  V K Kawai; J F Solus; A Oeser; Y H Rho; P Raggi; A Bian; T Gebretsadik; A Shintani; C M Stein
Journal:  Lupus       Date:  2011-10-05       Impact factor: 2.911

Review 5.  Endothelial function and endothelial progenitor cells in systemic lupus erythematosus.

Authors:  Anselm Mak; Jerry Kok Yen Chan
Journal:  Nat Rev Rheumatol       Date:  2022-04-07       Impact factor: 20.543

6.  Development of High Fat Diet-Induced Hyperinsulinemia in Mice Is Enhanced by Co-treatment With a TLR7 Agonist.

Authors:  Rahul M Kakalij; Del L Dsouza; Erika I Boesen
Journal:  Front Physiol       Date:  2022-07-06       Impact factor: 4.755

7.  Increased Risk of Multimorbidity in Patients With Sarcoidosis: A Population-Based Cohort Study 1976 to 2013.

Authors:  Patompong Ungprasert; Eric L Matteson; Cynthia S Crowson
Journal:  Mayo Clin Proc       Date:  2017-11-03       Impact factor: 7.616

8.  Importance of cumulative exposure to elevated cholesterol and blood pressure in development of atherosclerotic coronary artery disease in systemic lupus erythematosus: a prospective proof-of-concept cohort study.

Authors:  Mandana Nikpour; Murray B Urowitz; Dominique Ibanez; Paula J Harvey; Dafna D Gladman
Journal:  Arthritis Res Ther       Date:  2011-09-29       Impact factor: 5.156

9.  Assessment of cardiovascular risk tools as predictors of cardiovascular disease events in systemic lupus erythematosus.

Authors:  Jagan Sivakumaran; Paula Harvey; Ahmed Omar; Oshrat Tayer-Shifman; Murray B Urowitz; Dafna D Gladman; Nicole Anderson; Jiandong Su; Zahi Touma
Journal:  Lupus Sci Med       Date:  2021-05

10.  Increased arterial stiffness in systemic lupus erythematosus (SLE) patients at low risk for cardiovascular disease: a cross-sectional controlled study.

Authors:  Karim Sacre; Brigitte Escoubet; Blandine Pasquet; Marie-Paule Chauveheid; Maria-Christina Zennaro; Florence Tubach; Thomas Papo
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.